A detailed history of Cambridge Investment Research Advisors, Inc. transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 31,400 shares of TXG stock, worth $498,004. This represents 0.0% of its overall portfolio holdings.

Number of Shares
31,400
Holding current value
$498,004
% of portfolio
0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$15.71 - $23.49 $493,294 - $737,586
31,400 New
31,400 $709,000
Q1 2022

May 12, 2022

SELL
$55.7 - $145.79 $81,210 - $212,561
-1,458 Closed
0 $0
Q4 2021

Feb 03, 2022

BUY
$135.05 - $182.59 $6,482 - $8,764
48 Added 3.4%
1,458 $217,000
Q3 2021

Nov 02, 2021

BUY
$145.58 - $192.14 $11,355 - $14,986
78 Added 5.86%
1,410 $205,000
Q2 2021

Aug 10, 2021

BUY
$134.22 - $202.37 $9,261 - $13,963
69 Added 5.46%
1,332 $260,000
Q1 2021

May 07, 2021

SELL
$140.25 - $196.86 $157,360 - $220,876
-1,122 Reduced 47.04%
1,263 $228,000
Q4 2020

Feb 04, 2021

BUY
$126.47 - $163.7 $301,630 - $390,424
2,385 New
2,385 $337,000

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.51B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.